Figma's stock sinks more than 20% after last week's IPO pop

1 month ago 24

Dylan Field, co-founder and CEO of Figma, appears connected the level of the New York Stock Exchange successful New York connected July 31, 2025. Figma shares surged arsenic overmuch arsenic 229% aft the plan bundle shaper and immoderate of its shareholders raised $1.2 cardinal successful an IPO, with the trading valuing the institution acold supra the $20 cardinal people it would person reached successful a now-scrapped merger with Adobe Inc.

Michael Nagle | Bloomberg | Getty Images

Figma shares dropped 23% connected Monday, cutting into the gains the plan bundle institution posted aft hitting the marketplace past week.

The banal dropped $27.50 to $94.50 arsenic of mid-day. That's down from a adjacent of $122 connected Friday.

Figma and apical stockholders sold astir 37 cardinal shares astatine $33 per share precocious Wednesday, yielding astir $412 cardinal successful proceeds flowing to the company. On Thursday, its archetypal time of trading connected the New York Stock Exchange, the banal more than tripled.

The archetypal reception shows a renewed appetite connected Wall Street for high-growth exertion companies aft a historically dilatory agelong for IPOs.

Figma said successful an update IPO prospectus that it expects second-quarter gross to summation by astir 40% from a twelvemonth earlier. But dissimilar galore exertion companies that person gone nationalist successful the past respective years, Figma has regularly posted profits.

Figma's afloat diluted valuation sits astatine astir $56 billion, astir triple the magnitude Adobe agreed to wage successful its 2022 acquisition offer. Regulators successful the EU and the U.K. opposed the deal, which the 2 companies called off successful precocious 2023.

Dylan Field, Figma's 33-year-old CEO, owns stock successful the institution worthy implicit $5 cardinal adjacent aft Monday's slide.

WATCH: Figma much than triples successful NYSE debut aft selling shares astatine $33

Figma much  than triples successful  NYSE debut aft  selling shares astatine  $33

Read Entire Article